Andrew K Balo Insider Trading $DXCM DEXCOM INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew K Balo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew K Balo. Andrew K Balo is * in DEXCOM INC ($DXCM) and EVP, Clinical and Regulatory in DEXCOM INC ($DXCM) and EVP, Clinical, Regulatory in DEXCOM INC ($DXCM) and EVP, Reg. Strategy, Clinical in DEXCOM INC ($DXCM) and VP of Clinical & Regulatory in DEXCOM INC ($DXCM).
Andrew K Balo in DEXCOM INC
Trading Symbol: DXCMIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Andrew K Balo: *, EVP, Reg. Strategy, Clinical, EVP, Clinical and Regulatory, EVP, Clinical, Regulatory, VP of Clinical & Regulatory
Holdings: 35,307 shares
Current Value: $2,812,909
Latest Transaction: Mar 12 2021
$DXCM Market Capitalization: $6.75B
$DXCM Previous Close: $79.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew K Balo in DEXCOM INC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 15 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 95.93 | 4,416 | 423,638 | 133,770 | 138.2 K to 133.8 K (-3.20 %) |
Sep 11 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 90.90 | 4,404 | 400,317 | 138,186 | 142.6 K to 138.2 K (-3.09 %) |
Sep 09 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 89.53 | 7,500 | 671,447 | 142,590 | 150.1 K to 142.6 K (-5.00 %) |
Aug 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 92.47 | 7,500 | 693,500 | 150,090 | 157.6 K to 150.1 K (-4.76 %) |
Aug 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 95.04 | 7,500 | 712,775 | 157,590 | 165.1 K to 157.6 K (-4.54 %) |
Jul 24 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 84.78 | 10,214 | 865,922 | 165,033 | 175.2 K to 165 K (-5.83 %) |
Jul 09 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 80.22 | 4,494 | 360,510 | 175,247 | 179.7 K to 175.2 K (-2.50 %) |
Jun 25 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 5,573 | 54,615 | 0 | |
Jun 25 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 77.54 | 5,573 | 432,137 | 179,741 | 185.3 K to 179.7 K (-3.01 %) |
Jun 25 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 5,573 | 54,615 | 185,314 | 179.7 K to 185.3 K (+3.10 %) |
Jun 11 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 5,573 | |
Jun 11 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 70.62 | 7,500 | 529,659 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
Jun 11 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
May 20 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 13,073 | |
May 20 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 68.46 | 7,500 | 513,470 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
May 20 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
May 05 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 20,573 | |
May 05 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 67.99 | 7,500 | 509,903 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
May 05 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
Apr 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 28,073 | |
Apr 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 69.65 | 7,500 | 522,353 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
Apr 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
Apr 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 35,573 | |
Apr 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 64.55 | 7,500 | 484,149 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
Apr 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
Mar 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 43,073 | |
Mar 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 61.05 | 7,500 | 457,849 | 179,741 | 187.2 K to 179.7 K (-4.01 %) |
Mar 27 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 187,241 | 179.7 K to 187.2 K (+4.17 %) |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 50,573 | |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.58 | 4,448 | 260,548 | 179,741 | 184.2 K to 179.7 K (-2.41 %) |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 58.58 | 7,500 | 439,367 | 184,189 | 191.7 K to 184.2 K (-3.91 %) |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 191,689 | 184.2 K to 191.7 K (+4.07 %) |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.74 | 8,824 | 518,324 | 184,189 | 193 K to 184.2 K (-4.57 %) |
Mar 13 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 58.74 | 4,743 | 278,605 | 193,013 | 197.8 K to 193 K (-2.40 %) |
Mar 10 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Grant | A | 0.00 | 47,500 | 48 | 197,756 | 150.3 K to 197.8 K (+31.61 %) |
Feb 26 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Option Exercise | M | 9.80 | 7,500 | 73,500 | 58,073 | |
Feb 26 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | S | 62.22 | 7,500 | 466,637 | 150,256 | 157.8 K to 150.3 K (-4.75 %) |
Feb 26 2015 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Buy | M | 9.80 | 7,500 | 73,500 | 157,756 | 150.3 K to 157.8 K (+4.99 %) |
May 04 2006 | DXCM | DEXCOM INC | Balo Andrew K | VP of Clinical & Re ... | Option Exercise | M | 0.50 | 36,000 | 18,000 | 28,466 | |
May 04 2006 | DXCM | DEXCOM INC | Balo Andrew K | VP of Clinical & Re ... | Option Exercise | M | 0.30 | 11,500 | 3,450 | 0 | |
May 04 2006 | DXCM | DEXCOM INC | Balo Andrew K | VP of Clinical & Re ... | Sell | S | 24.00 | 100,000 | 2,400,000 | 876 | 100.9 K to 876 (-99.13 %) |
May 04 2006 | DXCM | DEXCOM INC | Balo Andrew K | VP of Clinical & Re ... | Buy | M | 0.50 | 36,000 | 18,000 | 100,876 | 64.9 K to 100.9 K (+55.49 %) |
May 04 2006 | DXCM | DEXCOM INC | Balo Andrew K | VP of Clinical & Re ... | Buy | M | 0.30 | 11,500 | 3,450 | 64,876 | 53.4 K to 64.9 K (+21.55 %) |